Skip to main content
NCBI home page
Biochemical Journal logoLink to Biochemical Journal
. 1998 Dec 15;336(Pt 3):625–630. doi: 10.1042/bj3360625

Cholesterol relieves the inhibitory effect of sphingomyelin on type II secretory phospholipase A2.

K S Koumanov 1, P J Quinn 1, G Béréziat 1, C Wolf 1
PMCID: PMC1219913  PMID: 9841874

Abstract

Secretory type II phospholipase A2 (sPLA2) is inhibited by sphingomyelin (SPH); cholesterol either mixed with the model glycerophospholipid substrate or added to the assay medium as separated liposomes counteracts this inhibition efficiently. The inhibition of fatty acid release assayed by quantitative gas chromatography-MS is observed when SPH is added to erythrocyte membranes as the substrate instead of a readily hydrolysable phosphatidylethanolamine/phosphatidylserine model mixture. Hydrolysis of SPH by Staphylococcus aureus sphingomyelinase suppresses its inhibitory potency. The addition of cholesterol to SPH liposomes with a 1:1 stoichiometry relieves completely the inhibition of sPLA2 exerted by SPH. The mechanism of inhibition suggested by the binding assay is that sPLA2 binds with affinity to the SPH interface, after either phase segregation at the assay temperature or on the pure SPH liposomes added to the incubation medium. Cholesterol is shown to suppress the binding affinity of the enzyme for the SPH interface. A model for inhibition is suggested in which binding of the sphingosine moiety is competitive for sPLA2 (inhibition) or for cholesterol (release of the enzyme).

Full Text

The Full Text of this article is available as a PDF (114.8 KB).

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Ahmed S. N., Brown D. A., London E. On the origin of sphingolipid/cholesterol-rich detergent-insoluble cell membranes: physiological concentrations of cholesterol and sphingolipid induce formation of a detergent-insoluble, liquid-ordered lipid phase in model membranes. Biochemistry. 1997 Sep 9;36(36):10944–10953. doi: 10.1021/bi971167g. [DOI] [PubMed] [Google Scholar]
  2. Bar L. K., Barenholz Y., Thompson T. E. Effect of sphingomyelin composition on the phase structure of phosphatidylcholine-sphingomyelin bilayers. Biochemistry. 1997 Mar 4;36(9):2507–2516. doi: 10.1021/bi9625004. [DOI] [PubMed] [Google Scholar]
  3. Berenbaum F., Jacques C., Thomas G., Corvol M. T., Béréziat G., Masliah J. Synergistic effect of interleukin-1 beta and tumor necrosis factor alpha on PGE2 production by articular chondrocytes does not involve PLA2 stimulation. Exp Cell Res. 1996 Feb 1;222(2):379–384. doi: 10.1006/excr.1996.0047. [DOI] [PubMed] [Google Scholar]
  4. Bittman R., Kasireddy C. R., Mattjus P., Slotte J. P. Interaction of cholesterol with sphingomyelin in monolayers and vesicles. Biochemistry. 1994 Oct 4;33(39):11776–11781. doi: 10.1021/bi00205a013. [DOI] [PubMed] [Google Scholar]
  5. Boggs J. M. Lipid intermolecular hydrogen bonding: influence on structural organization and membrane function. Biochim Biophys Acta. 1987 Oct 5;906(3):353–404. doi: 10.1016/0304-4157(87)90017-7. [DOI] [PubMed] [Google Scholar]
  6. Bolin D. J., Jonas A. Sphingomyelin inhibits the lecithin-cholesterol acyltransferase reaction with reconstituted high density lipoproteins by decreasing enzyme binding. J Biol Chem. 1996 Aug 9;271(32):19152–19158. doi: 10.1074/jbc.271.32.19152. [DOI] [PubMed] [Google Scholar]
  7. Bradford M. M. A rapid and sensitive method for the quantitation of microgram quantities of protein utilizing the principle of protein-dye binding. Anal Biochem. 1976 May 7;72:248–254. doi: 10.1016/0003-2697(76)90527-3. [DOI] [PubMed] [Google Scholar]
  8. Brown D. A., Rose J. K. Sorting of GPI-anchored proteins to glycolipid-enriched membrane subdomains during transport to the apical cell surface. Cell. 1992 Feb 7;68(3):533–544. doi: 10.1016/0092-8674(92)90189-j. [DOI] [PubMed] [Google Scholar]
  9. Chap H. J., Zwaal R. F., van Deenen L. L. Action of highly purified phospholipases on blood platelets. Evidence for an asymmetric distribution of phospholipids in the surface membrane. Biochim Biophys Acta. 1977 Jun 2;467(2):146–164. doi: 10.1016/0005-2736(77)90192-4. [DOI] [PubMed] [Google Scholar]
  10. Chapman D., Owens N. F., Phillips M. C., Walker D. A. Mixed monolayers of phospholipids and cholesterol. Biochim Biophys Acta. 1969;183(3):458–465. doi: 10.1016/0005-2736(69)90160-6. [DOI] [PubMed] [Google Scholar]
  11. Dawson R. M., Hemington N., Irvine R. F. The inhibition of diacylglycerol-stimulated intracellular phospholipases by phospholipids with a phosphocholine-containing polar group. A possible physiological role for sphingomyelin. Biochem J. 1985 Aug 15;230(1):61–68. doi: 10.1042/bj2300061. [DOI] [PMC free article] [PubMed] [Google Scholar]
  12. Dennis E. A. Diversity of group types, regulation, and function of phospholipase A2. J Biol Chem. 1994 May 6;269(18):13057–13060. [PubMed] [Google Scholar]
  13. Fourcade O., Simon M. F., Viodé C., Rugani N., Leballe F., Ragab A., Fournié B., Sarda L., Chap H. Secretory phospholipase A2 generates the novel lipid mediator lysophosphatidic acid in membrane microvesicles shed from activated cells. Cell. 1995 Mar 24;80(6):919–927. doi: 10.1016/0092-8674(95)90295-3. [DOI] [PubMed] [Google Scholar]
  14. Franson R. C., Harris L. K., Ghosh S. S., Rosenthal M. D. Sphingolipid metabolism and signal transduction: inhibition of in vitro phospholipase activity by sphingosine. Biochim Biophys Acta. 1992 Aug 12;1136(2):169–174. doi: 10.1016/0167-4889(92)90253-8. [DOI] [PubMed] [Google Scholar]
  15. Hannun Y. A., Bell R. M. Functions of sphingolipids and sphingolipid breakdown products in cellular regulation. Science. 1989 Jan 27;243(4890):500–507. doi: 10.1126/science.2643164. [DOI] [PubMed] [Google Scholar]
  16. Hannun Y. A. The sphingomyelin cycle and the second messenger function of ceramide. J Biol Chem. 1994 Feb 4;269(5):3125–3128. [PubMed] [Google Scholar]
  17. Hønger T., Jørgensen K., Biltonen R. L., Mouritsen O. G. Systematic relationship between phospholipase A2 activity and dynamic lipid bilayer microheterogeneity. Biochemistry. 1996 Jul 16;35(28):9003–9006. doi: 10.1021/bi960866a. [DOI] [PubMed] [Google Scholar]
  18. Koumanov K., Wolf C., Béreziat G. Modulation of human type II secretory phospholipase A2 by sphingomyelin and annexin VI. Biochem J. 1997 Aug 15;326(Pt 1):227–233. doi: 10.1042/bj3260227. [DOI] [PMC free article] [PubMed] [Google Scholar]
  19. Leslie C. C., Channon J. Y. Anionic phospholipids stimulate an arachidonoyl-hydrolyzing phospholipase A2 from macrophages and reduce the calcium requirement for activity. Biochim Biophys Acta. 1990 Aug 6;1045(3):261–270. doi: 10.1016/0005-2760(90)90129-l. [DOI] [PubMed] [Google Scholar]
  20. Liu P., Anderson R. G. Compartmentalized production of ceramide at the cell surface. J Biol Chem. 1995 Nov 10;270(45):27179–27185. doi: 10.1074/jbc.270.45.27179. [DOI] [PubMed] [Google Scholar]
  21. Liu P., Anderson R. G. Compartmentalized production of ceramide at the cell surface. J Biol Chem. 1995 Nov 10;270(45):27179–27185. doi: 10.1074/jbc.270.45.27179. [DOI] [PubMed] [Google Scholar]
  22. Lobo L. I., Wilton D. C. Combined effects of sphingomyelin and cholesterol on the hydrolysis of emulsion particle triolein by lipoprotein lipase. Biochim Biophys Acta. 1997 Nov 15;1349(2):122–130. doi: 10.1016/s0005-2760(97)00127-6. [DOI] [PubMed] [Google Scholar]
  23. Lund-Katz S., Laboda H. M., McLean L. R., Phillips M. C. Influence of molecular packing and phospholipid type on rates of cholesterol exchange. Biochemistry. 1988 May 3;27(9):3416–3423. doi: 10.1021/bi00409a044. [DOI] [PubMed] [Google Scholar]
  24. Momchilova A., Petkova D., Mechev I., Dimitrov G., Koumanov K. Sensitivity of 5'-nucleotidase and phospholipase A2 towards liver plasma membranes modifications. Int J Biochem. 1985;17(7):787–792. doi: 10.1016/0020-711x(85)90265-4. [DOI] [PubMed] [Google Scholar]
  25. Obeid L. M., Linardic C. M., Karolak L. A., Hannun Y. A. Programmed cell death induced by ceramide. Science. 1993 Mar 19;259(5102):1769–1771. doi: 10.1126/science.8456305. [DOI] [PubMed] [Google Scholar]
  26. Pernas P., Masliah J., Olivier J. L., Salvat C., Rybkine T., Bereziat G. Type II phospholipase A2 recombinant overexpression enhances stimulated arachidonic acid release. Biochem Biophys Res Commun. 1991 Aug 15;178(3):1298–1305. doi: 10.1016/0006-291x(91)91035-b. [DOI] [PubMed] [Google Scholar]
  27. Pfeilschifter J., Schalkwijk C., Briner V. A., van den Bosch H. Cytokine-stimulated secretion of group II phospholipase A2 by rat mesangial cells. Its contribution to arachidonic acid release and prostaglandin synthesis by cultured rat glomerular cells. J Clin Invest. 1993 Nov;92(5):2516–2523. doi: 10.1172/JCI116860. [DOI] [PMC free article] [PubMed] [Google Scholar]
  28. Scarlata S., Gupta R., Garcia P., Keach H., Shah S., Kasireddy C. R., Bittman R., Rebecchi M. J. Inhibition of phospholipase C-delta 1 catalytic activity by sphingomyelin. Biochemistry. 1996 Nov 26;35(47):14882–14888. doi: 10.1021/bi961072z. [DOI] [PubMed] [Google Scholar]
  29. Schnitzer J. E., McIntosh D. P., Dvorak A. M., Liu J., Oh P. Separation of caveolae from associated microdomains of GPI-anchored proteins. Science. 1995 Sep 8;269(5229):1435–1439. doi: 10.1126/science.7660128. [DOI] [PubMed] [Google Scholar]
  30. Schroeder R., London E., Brown D. Interactions between saturated acyl chains confer detergent resistance on lipids and glycosylphosphatidylinositol (GPI)-anchored proteins: GPI-anchored proteins in liposomes and cells show similar behavior. Proc Natl Acad Sci U S A. 1994 Dec 6;91(25):12130–12134. doi: 10.1073/pnas.91.25.12130. [DOI] [PMC free article] [PubMed] [Google Scholar]
  31. Smaby J. M., Brockman H. L., Brown R. E. Cholesterol's interfacial interactions with sphingomyelins and phosphatidylcholines: hydrocarbon chain structure determines the magnitude of condensation. Biochemistry. 1994 Aug 9;33(31):9135–9142. doi: 10.1021/bi00197a016. [DOI] [PMC free article] [PubMed] [Google Scholar]
  32. Steck T. L., Kant J. A. Preparation of impermeable ghosts and inside-out vesicles from human erythrocyte membranes. Methods Enzymol. 1974;31:172–180. doi: 10.1016/0076-6879(74)31019-1. [DOI] [PubMed] [Google Scholar]
  33. Subbaiah P. V., Liu M. Role of sphingomyelin in the regulation of cholesterol esterification in the plasma lipoproteins. Inhibition of lecithin-cholesterol acyltransferase reaction. J Biol Chem. 1993 Sep 25;268(27):20156–20163. [PubMed] [Google Scholar]
  34. Thompson T. E., Tillack T. W. Organization of glycosphingolipids in bilayers and plasma membranes of mammalian cells. Annu Rev Biophys Biophys Chem. 1985;14:361–386. doi: 10.1146/annurev.bb.14.060185.002045. [DOI] [PubMed] [Google Scholar]
  35. Tsujishita Y., Asaoka Y., Nishizuka Y. Regulation of phospholipase A2 in human leukemia cell lines: its implication for intracellular signaling. Proc Natl Acad Sci U S A. 1994 Jul 5;91(14):6274–6278. doi: 10.1073/pnas.91.14.6274. [DOI] [PMC free article] [PubMed] [Google Scholar]
  36. Zachowski A. Phospholipids in animal eukaryotic membranes: transverse asymmetry and movement. Biochem J. 1993 Aug 15;294(Pt 1):1–14. doi: 10.1042/bj2940001. [DOI] [PMC free article] [PubMed] [Google Scholar]

Articles from Biochemical Journal are provided here courtesy of The Biochemical Society

RESOURCES